Survival outcomes and prognostic factors of infratentorial glioblastoma in the elderly.

Brain stem Cerebellum Elderly Glioblastoma Infratentorial

Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
13 Dec 2023
Historique:
received: 10 12 2023
accepted: 11 12 2023
medline: 24 12 2023
pubmed: 24 12 2023
entrez: 23 12 2023
Statut: aheadofprint

Résumé

Infratentorial glioblastoma(itGBM) is a rare and rapidly progressive form of GBM with poor prognosis. However, no studies have adequately examined itGBM outcomes in elderly patients (>65 years). Here, we used a national database to fill this knowledge gap. SEER 18 registries were utilized to identify adult itGBM patients diagnosed between 2000-2016. itGBM cases were further divided into cerebellar and brainstem GBM as cGBM and bGBM, respectively. Kaplan-Meier analysis and Cox hazards proportional regression models were performed to assess factors associated with overall survival (OS). Among 137 (33%) elderly patients from the study cohort (N = 420), median age was 74 years, 38% were female, and 85% were white. Median OS in elderly itGBM patients was shorter than younger adults (10 vs. 5-months, p < 0.001). Multivariate analysis by tumor location revealed that older age was associated with poor survival for cGBM, but not for bGBM. Gross-total resection (GTR) was associated with better outcomes for both cGBM and bGBM. Radiotherapy had survival benefits for cGBM; meanwhile, chemotherapy prolonged OS in bGBM. In the elderly, advanced age (80 + years) was associated with poor outcomes, while GTR, CT and RT were all associated with improved survival. In our study, while elderly patients had worse survival compared to younger adults for both cGBM and bGBM, GTR improved OS in elderly itGBM, with CT and RT exhibiting a location-dependent survival benefit. Thus, elderly itGBM patients should undergo a combination of maximal resection and adjuvant treatment guided by infratentorial tumor location for maximal survival benefit.

Identifiants

pubmed: 38141552
pii: S0303-8467(23)00500-0
doi: 10.1016/j.clineuro.2023.108084
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108084

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Auteurs

Ankush Chandra (A)

Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Victor Lopez-Rivera (V)

Department of Neurosurgery, Emory University, Atlanta, GA, USA.

Bryan Ryba (B)

Department of Neurosurgery, University of California, La Jolla, San Diego, CA, USA.

Arjun S Chandran (AS)

Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Michael G Brandel (MG)

Department of Neurosurgery, University of California, La Jolla, San Diego, CA, USA.

Antonio Dono (A)

Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Dallas L Sheinberg (DL)

Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Yoshua L Esquenazi (YL)

Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Manish K Aghi (MK)

Department of Neurological Surgery, University of California, San Francisco; San Francisco, CA 94131, USA. Electronic address: manish.aghi@ucsf.edu.

Classifications MeSH